[Diabetogenic factor in the blood plasma in diabetes mellitus]

B A Kudriashov, G V Ponasenkova, Iu A Pytel'

Problemy Endokrinologii

|September 1, 1982

Abstract:

The blood plasma of rats with stable alloxan diabetes, injected three times in appropriate intravenous doses to intact rats, provoked in the rats-recipients hyperglycemia and hyperuricemia, persisted within 14 days. Under the same conditions the blood plasma of patients with diabetes mellitus induced hyperglycemia in the rats-recipients without hyperuricemia development during the same time period. A preliminary intravenous injection of heparin in a dose of 100 E (5 minutes before injecting the plasma of rats with alloxan diabetes or the plasma of patients with diabetes mellitus) completely prevented hyperglycemia and hyperuricemia development in the recipients. Intravenous injections of the blood plasma of healthy animals and humans did not provoke hyperglycemia and hyperuricemia arising in the rats-recipients. It is concluded, that in the blood plasma of animals with alloxan diabetes and in patients with diabetes mellitus the diabetogenic factor is present, being deactivated under heparin effect.

Related Experiment Videos

[Diabetogenic factor in the blood plasma in diabetes mellitus]

Related Concept Videos

[The results of long-term permixon treatment in patients with symptoms of lower urinary tracts dysfunction due to benign prostatic hyperplasia].

[Role of electrochemical potential in urinary tract function].

[Mineral water Volzhanka from Undorovskĭ spring in combined therapy of patients with nephrolithiasis and chronic pyelonephritis].

[Drug-induced polyuria in the surgical treatment of patients with nephrolithiasis].

[beta 2-Adrenomimetics before and after extracorporeal lithotripsy].

[Drainage of the urinary tract as preparation for extracorporeal lithotripsy].

[Clinical practice guidelines "Congenital adrenal hyperplasia in children" with comments].

[Microcephalic osteodysplastic primary dwarfism type II with hypergonadotropic hypogonadism in a 16-year-old patient].

[Radioiodine-Refractory Differentiated Thyroid Carcinoma in Children and Adolescents: A Retrospective Study].

Semaglutide-Induced Sarcopenia via GLP-1R-mTOR-Satellite Cells Axis and Muscle-Glucose Feedback Loop Potentially Leading to Refractory Hyperglycemia in Type 2 Diabetes: A Case-Driven Hypothesis.

[Regional features of the main indicators of carbohydrate metabolism in young residents of various climatic and geographical zones of residence].

Metformin's disruption of gluconeogenesis in type 2 diabetes impairments of the cori and alanine cycles as hidden drivers of metabolic waste accumulation, NF-κBHIF-1α-mediated low-grade inflammation, and multisystem dysfunction.

Latent Classes of Inflammation-Nutrition-Metabolism Status in Maintenance Hemodialysis: Associations with Arteriovenous Fistula Function and Cardiovascular Prognosis.

Transhepatic Gradients Reveal Selective Hepatic Processing Defects With Systemic Consequences in Cirrhosis.

Integrated metabolomic and gut microbiota analyses reveal TCA cycle dysfunction in broiler skeletal disorders and the protective effect of L‑malic acid.

Integrated metabolomics and DNA methylation signatures and their association with flare remission in SLE.

Immune metabolic reprogramming in MASLD.

Macrophage HDAC3 drives obesity and adipose tissue metabolic maladaptation through GDF3-mediated inflammation and chromatin remodeling.

Related Experiment Videos

[Diabetogenic factor in the blood plasma in diabetes mellitus]

Abstract:

Related Concept Videos

Related Articles